Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 3
1992 2
1995 2
2003 1
2004 2
2005 2
2006 3
2007 2
2008 5
2009 3
2010 2
2011 3
2012 3
2014 6
2015 9
2016 7
2017 14
2018 8
2019 3
2020 5
2021 7
2022 7
2023 13
2024 10
2025 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

115 results

Results by year

Filters applied: . Clear all
Page 1
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.
Khanna D, Lin CJF, Furst DE, Goldin J, Kim G, Kuwana M, Allanore Y, Matucci-Cerinic M, Distler O, Shima Y, van Laar JM, Spotswood H, Wagner B, Siegel J, Jahreis A, Denton CP; focuSSced investigators. Khanna D, et al. Lancet Respir Med. 2020 Oct;8(10):963-974. doi: 10.1016/S2213-2600(20)30318-0. Epub 2020 Aug 28. Lancet Respir Med. 2020. PMID: 32866440 Clinical Trial.
Pathological autoantibody internalisation in myositis.
Pinal-Fernandez I, Muñoz-Braceras S, Casal-Dominguez M, Pak K, Torres-Ruiz J, Musai J, Dell'Orso S, Naz F, Islam S, Gutierrez-Cruz G, Cano MD, Matas-Garcia A, Padrosa J, Tobias-Baraja E, Garrabou G, Aldecoa I, Espinosa G, Simeon-Aznar CP, Guillen-Del-Castillo A, Gil-Vila A, Trallero-Araguás E, Christopher-Stine L, Lloyd TE, Liewluck T, Naddaf E, Stenzel W, Greenberg SA, Grau JM, Selva-O'Callaghan A, Milisenda JC, Mammen AL. Pinal-Fernandez I, et al. Among authors: simeon aznar cp. Ann Rheum Dis. 2024 Oct 21;83(11):1549-1560. doi: 10.1136/ard-2024-225773. Ann Rheum Dis. 2024. PMID: 38902010 Free article.
[Scleroderma].
Fonollosa Pla V, Simeón Aznar CP. Fonollosa Pla V, et al. Among authors: simeon aznar cp. Med Clin (Barc). 2004 Mar 27;122(11):418-9. doi: 10.1016/s0025-7753(04)74258-x. Med Clin (Barc). 2004. PMID: 15066250 Spanish. No abstract available.
Systemic sclerosis associated myopathy: how to treat.
Selva-O'Callaghan A, Guillen-Del-Castillo A, Gil-Vila A, Trallero-Araguás E, Matas-García A, Milisenda JC, Pinal-Fernández I, Simeón-Aznar C. Selva-O'Callaghan A, et al. Among authors: simeon aznar c. Curr Treatm Opt Rheumatol. 2023 Dec;9(4):151-167. doi: 10.1007/s40674-023-00206-y. Epub 2023 Jul 19. Curr Treatm Opt Rheumatol. 2023. PMID: 38737329 Free PMC article.
Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database.
Lescoat A, Huang S, Carreira PE, Siegert E, de Vries-Bouwstra J, Distler JHW, Smith V, Del Galdo F, Anic B, Damjanov N, Rednic S, Ribi C, Bancel DF, Hoffmann-Vold AM, Gabrielli A, Distler O, Khanna D, Allanore Y; EUSTAR collaborators. Lescoat A, et al. JAMA Dermatol. 2023 Aug 1;159(8):837-847. doi: 10.1001/jamadermatol.2023.1729. JAMA Dermatol. 2023. PMID: 37378994 Free PMC article.
[Raynaud's phenomenon].
Tolosa Vilella C, Simeón Aznar CP, Gabarró Julià L. Tolosa Vilella C, et al. Among authors: simeon aznar cp. Med Clin (Barc). 2009 May 16;132(18):712-8. doi: 10.1016/j.medcli.2008.11.017. Epub 2009 Mar 6. Med Clin (Barc). 2009. PMID: 19268319 Free article. Review. Spanish.
Identifying the risk of cancer-associated systemic sclerosis.
Guillen-Del-Castillo A, Simeón-Aznar CP. Guillen-Del-Castillo A, et al. Among authors: simeon aznar cp. Joint Bone Spine. 2023 Dec;90(6):105618. doi: 10.1016/j.jbspin.2023.105618. Epub 2023 Jul 22. Joint Bone Spine. 2023. PMID: 37482176 No abstract available.
Treatment and Monitoring of Eosinophilic Fasciitis.
Selva-O'Callaghan A, Trallero-Araguás E, Gil-Vila A, Guillen-Del Castillo A, Matas-García A, Milisenda JC, Simeon-Aznar CP, Pinal-Fernandez I. Selva-O'Callaghan A, et al. Among authors: simeon aznar cp. Curr Treatm Opt Rheumatol. 2025;11:3. doi: 10.1007/s40674-024-00222-6. Epub 2025 Jan 23. Curr Treatm Opt Rheumatol. 2025. PMID: 40115529
Deep hierarchical subtyping of multi-organ systemic sclerosis trajectories - a EUSTAR study.
Trottet C, Schürch M, Allam A, Petelytska L, Castellví I, Bečvář R, de Vries-Bouwstra J, Iannone F, Carreira P, Truchetet ME, Cuomo G, Rezus E, Cantatore FP, Simeón-Aznar CP, Parvu M, Dzhus M, Distler O, Hoffmann-Vold AM, Krauthammer M; EUSTAR Collaborators. Trottet C, et al. Among authors: simeon aznar cp. NPJ Digit Med. 2025 Sep 1;8(1):563. doi: 10.1038/s41746-025-01962-y. NPJ Digit Med. 2025. PMID: 40890392 Free PMC article.
Expanding the landscape of systemic sclerosis-related autoantibodies through RNA immunoprecipitation coupled with massive parallel sequencing.
Perurena-Prieto J, Sanz-Martínez MT, Viñas-Giménez L, Codina-Clavaguera C, Triginer L, Gordillo-González F, Andrés-León E, Batlle-Masó L, Martin J, Selva-O'Callaghan A, Pujol R, McHugh NJ, Tansley SL, Colobran R, Guillen-Del-Castillo A, Simeón-Aznar CP. Perurena-Prieto J, et al. Among authors: simeon aznar cp. J Autoimmun. 2024 Dec;149:103328. doi: 10.1016/j.jaut.2024.103328. Epub 2024 Nov 4. J Autoimmun. 2024. PMID: 39500147
115 results